Mira Shoukry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mira Shoukry has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Emmanuel Gabriel
Mayo Clinic, Jacksonville, USA
2 shared publications - Alexander Shusko
From the Mayo Clinic Alix School of Medicine, Scottsdale, Arizona (Shoukry, Lopez-Ruiz); Department of Ophthalmology, Mayo Clinic, Scottsdale, Arizona (Patel, Shusko)
1 shared publication - Ali Abbaszadeh Kasbi
Department of Surgery, Section of Surgical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA
1 shared publication Andrea Bs Lopez-Ruiz
From the Mayo Clinic Alix School of Medicine, Scottsdale, Arizona (Shoukry, Lopez-Ruiz); Department of Ophthalmology, Mayo Clinic, Scottsdale, Arizona (Patel, Shusko)
1 shared publicationAudrey M. PhD Elegbede
M. Shoukry, O. Adeleye, B. Dillard, I. Abdulwadood, S. Wu, Mayo Clinic Alix School of Medicine, Scottsdale, AZ; R. Abdelwahab, Mayo Clinic Alix School of Medicine, Rochester, MN; E.M. Valencia, M.T. Keddis, A.M. Elegbede, S.J. Atunah-Jay, Mayo Clinic Alix School of Medicine
1 shared publicationBrionne Mba Dillard
M. Shoukry, O. Adeleye, B. Dillard, I. Abdulwadood, S. Wu, Mayo Clinic Alix School of Medicine, Scottsdale, AZ; R. Abdelwahab, Mayo Clinic Alix School of Medicine, Rochester, MN; E.M. Valencia, M.T. Keddis, A.M. Elegbede, S.J. Atunah-Jay, Mayo Clinic Alix School of Medicine
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery Online Case Reports
- Vol. 13, e00146
Retained lens fragment causing anterior uveitis four years after successful phacoemulsification
Introduction: Existing literature has detailed occurrences of retained cataract lens fragments identified days to weeks after cataract surgery. However, lens fragments in the anterior chamber remaining asymptomatic for several years are extremely rare, thus remaining a diagnostic challenge. A complex case of a retained lens fragment causing anterior uveitis 4 years after phacoemulsification is presented. Patient and Clinical Findings: A 76-year-old woman presented with a chief concern of right eye pain, photosensitivity, and blurred vision after head trauma. Diagnosis, Intervention, and Outcomes: Diagnostic imaging ruled out the presence of orbital fracture or globe deformity leading to an initial diagnosis of traumatic iritis. Initial management with topical corticosteroids did not improve symptoms. Subsequent slit lamp examination revealed a small cataract lens fragment in the anterior chamber leading to a diagnosis of anterior uveitis secondary to the retained lens. Anterior chamber washout was performed with successful removal of the fragment, and the patient reported resolution of pain and photosensitivity postoperatively. Conclusions: Owing to its rarity, diagnostic and treatment standards for retained cataract lens fragments have not yet been sufficiently explored. This case suggests that head trauma may be a precipitating event causing delayed onset of symptoms. Cataract lens retention should be considered in patients presenting with uveitis years after cataract surgery.
- 1 January 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery Online Case Reports
- Vol. 13, e00146
Open AccessRetained lens fragment causing anterior uveitis four years after successful phacoemulsification
Introduction: Existing literature has detailed occurrences of retained cataract lens fragments identified days to weeks after cataract surgery. However, lens fragments in the anterior chamber remaining asymptomatic for several years are extremely rare, thus remaining a diagnostic challenge. A complex case of a retained lens fragment causing anterior uveitis 4 years after phacoemulsification is presented. Patient and Clinical Findings: A 76-year-old woman presented with a chief concern of right eye pain, photosensitivity, and blurred vision after head trauma. Diagnosis, Intervention, and Outcomes: Diagnostic imaging ruled out the presence of orbital fracture or globe deformity leading to an initial diagnosis of traumatic iritis. Initial management with topical corticosteroids did not improve symptoms. Subsequent slit lamp examination revealed a small cataract lens fragment in the anterior chamber leading to a diagnosis of anterior uveitis secondary to the retained lens. Anterior chamber washout was performed with successful removal of the fragment, and the patient reported resolution of pain and photosensitivity postoperatively. Conclusions: Owing to its rarity, diagnostic and treatment standards for retained cataract lens fragments have not yet been sufficiently explored. This case suggests that head trauma may be a precipitating event causing delayed onset of symptoms. Cataract lens retention should be considered in patients presenting with uveitis years after cataract surgery.
- 16 October 2023
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 98 (Supplement) , S188-S189
Student Teaching Assistant Support Program for Diversity, Equity, Inclusion, and Antiracism Curriculum Integration
- 16 October 2023
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 98 (Supplement) , S188-S189
Student Teaching Assistant Support Program for Diversity, Equity, Inclusion, and Antiracism Curriculum Integration
- 16 September 2023
- Published by SAGE Publications in HAND
- Vol. 19 (8) , 1189-1194
The Role of Surgery in the Management of Radiation-Induced Brachial Plexopathy
Radiation-induced brachial plexopathy (RIBP) is a rare long-term complication of radiation therapy often causing pain, motor deficit, and overall quality of life reduction for affected patients. While a standard treatment for RIBP is yet to be established, management consists mostly of symptom management through the use of medications and physical therapy. There is a lack of evidence regarding the efficacy of surgical treatment. Omentoplasties and other vascularized flaps are commonly discussed options for eliminating neuropathic pain associated with RIBP. However, these approaches show no meaningful improvement in motor function. While limited, current literature suggests that nerve transfers may be an option for relief of neuropathic pain as well as restoration of motor function. This review of literature explores the options available to those affected by RIBP with a focus on the role of surgery.
- 16 September 2023
- Published by SAGE Publications in HAND
- Vol. 19 (8) , 1189-1194
The Role of Surgery in the Management of Radiation-Induced Brachial Plexopathy
Radiation-induced brachial plexopathy (RIBP) is a rare long-term complication of radiation therapy often causing pain, motor deficit, and overall quality of life reduction for affected patients. While a standard treatment for RIBP is yet to be established, management consists mostly of symptom management through the use of medications and physical therapy. There is a lack of evidence regarding the efficacy of surgical treatment. Omentoplasties and other vascularized flaps are commonly discussed options for eliminating neuropathic pain associated with RIBP. However, these approaches show no meaningful improvement in motor function. While limited, current literature suggests that nerve transfers may be an option for relief of neuropathic pain as well as restoration of motor function. This review of literature explores the options available to those affected by RIBP with a focus on the role of surgery.
- Open Access
Advanced Tumor Imaging Approaches in Human Tumors
The management of cancer has always relied heavily on the imaging modalities used to detect and monitor it. While many of these modalities have been around for decades, the technology surrounding them is always improving, and much has been discovered in recent years about the nature of tumors because of this. There have been several areas that have aided those discoveries. The use of artificial intelligence has already helped immensely in the quality of images taken but has not yet been widely implemented in clinical settings. Molecular imaging has proven to be useful in diagnosing different types of cancers based on the specificity of the probes/contrast agents used. Intravital imaging has already uncovered new information regarding the heterogeneity of the tumor vasculature. These three areas have provided a lot of useful information for the diagnosis and treatment of cancer, but further research and development in human trials is necessary to allow these techniques to fully utilize the information obtained thus far.
Open AccessAdvanced Tumor Imaging Approaches in Human Tumors
The management of cancer has always relied heavily on the imaging modalities used to detect and monitor it. While many of these modalities have been around for decades, the technology surrounding them is always improving, and much has been discovered in recent years about the nature of tumors because of this. There have been several areas that have aided those discoveries. The use of artificial intelligence has already helped immensely in the quality of images taken but has not yet been widely implemented in clinical settings. Molecular imaging has proven to be useful in diagnosing different types of cancers based on the specificity of the probes/contrast agents used. Intravital imaging has already uncovered new information regarding the heterogeneity of the tumor vasculature. These three areas have provided a lot of useful information for the diagnosis and treatment of cancer, but further research and development in human trials is necessary to allow these techniques to fully utilize the information obtained thus far.
- Open Access
- 30 September 2021
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 22, e933258-1-e933258-4
Management of a Primary Retroperitoneal Yolk Sac Tumor
Management of a Primary Retroperitoneal Yolk Sac Tumor - Article abstract #933258
- 30 September 2021
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 22, e933258-1-e933258-4
Open AccessManagement of a Primary Retroperitoneal Yolk Sac Tumor
Management of a Primary Retroperitoneal Yolk Sac Tumor - Article abstract #933258
- Open Access
The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer
With the incidence of breast cancer steadily rising, it is important to explore novel technologies that can allow for earlier detection of disease as well more a personalized and effective treatment approach. The concept of “liquid biopsies” and the data they provide have been increasingly studied in the recent decades. More specifically, circulating tumor DNA (ctDNA) has emerged as a potential biomarker for various cancers, including breast cancer. While methods such as mammography and tissue biopsies are the current standards for the detection and surveillance of breast cancer, ctDNA analysis has shown some promise. This review discusses the versatility of ctDNA by exploring its multiple emerging uses for the management of breast cancer. Its efficacy is also compared to current biomarkers and technologies.
Open AccessThe Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer
With the incidence of breast cancer steadily rising, it is important to explore novel technologies that can allow for earlier detection of disease as well more a personalized and effective treatment approach. The concept of “liquid biopsies” and the data they provide have been increasingly studied in the recent decades. More specifically, circulating tumor DNA (ctDNA) has emerged as a potential biomarker for various cancers, including breast cancer. While methods such as mammography and tissue biopsies are the current standards for the detection and surveillance of breast cancer, ctDNA analysis has shown some promise. This review discusses the versatility of ctDNA by exploring its multiple emerging uses for the management of breast cancer. Its efficacy is also compared to current biomarkers and technologies.